Sotera Health Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,189	1,164	1,100	1,049	1,004	931.48
Revenue Growth (YoY)	7.44%	5.74%	4.88%	4.54%	7.75%	13.85%
Cost of Revenue	531.97	518.08	498.15	472.13	446.68	412.81
Gross Profit	657.17	645.53	602.3	577.16	557	518.67
Selling, General & Admin	257.91	252.76	242.63	236.67	245.71	198.16
Depreciation & Amortization Expenses	18.44	30.74	62.04	63.8	62.94	63.78
Total Operating Expenses	276.35	283.5	304.67	300.47	308.65	261.94
Operating Income	380.82	362.03	297.63	276.69	248.35	256.73
Interest Expense	-149.59	-155.72	-164.69	-142.88	-80.14	-74.19
Other Non-Operating Income (Expense)	-24.67	-58.81	-19.06	-27.79	-411.32	-6.83
Total Non-Operating Income (Expense)	-174.26	-214.53	-183.75	-170.67	-491.46	-81.02
Pretax Income	204.94	147.51	113.87	106.03	-243.11	175.72
Provision for Income Taxes	87.14	69.56	69.48	54.65	-9.54	58.6
Net Income	117.8	77.95	44.4	51.38	-233.57	117.12
Minority Interest in Earnings	-	-	-	-	-	0.24
Net Income to Common	117.8	77.95	44.4	51.38	-233.57	116.88
Net Income Growth	374.71%	75.57%	-13.58%	-	-	-
Shares Outstanding (Basic)	284	284	283	281	280	279
Shares Outstanding (Diluted)	287	286	285	283	280	279
Shares Change (YoY)	0.72%	0.53%	0.60%	1.12%	0.26%	17.54%
EPS (Basic)	0.41	0.27	0.16	0.18	-0.83	0.41
EPS (Diluted)	0.41	0.27	0.16	0.18	-0.83	0.41
EPS Growth	412.50%	68.75%	-11.11%	-	-	-
Free Cash Flow	96.84	149.18	45.09	-362.71	95.58	179.38
Free Cash Flow Growth	-35.08%	230.81%	-	-	-46.72%	167.42%
Free Cash Flow Per Share	0.34	0.52	0.16	-1.28	0.34	0.64
Gross Margin	55.26%	55.48%	54.73%	55.00%	55.50%	55.68%
Operating Margin	32.02%	31.11%	27.05%	26.37%	24.74%	27.56%
Profit Margin	9.91%	6.70%	4.03%	4.90%	-23.27%	12.57%
FCF Margin	8.14%	12.82%	4.10%	-34.57%	9.52%	19.26%
EBITDA	507.53	498.74	461.26	434.62	393.9	407.64
EBITDA Margin	42.68%	42.86%	41.92%	41.42%	39.25%	43.76%
EBIT	380.82	362.03	297.63	276.69	248.35	256.73
EBIT Margin	32.02%	31.11%	27.05%	26.37%	24.74%	27.56%
Effective Tax Rate	42.52%	47.16%	61.01%	51.54%	3.92%	33.35%

SEC Filings: 10-K · 10-Q